In EBV + DLBCL, NOS, the activation of the JAK/STAT and NF-kB pathways, which triggers the expression of phosphorylated STAT3 and NF-kB, are more frequent in comparison with EBV-negative DLBCL [41,56]. The gene discussed is STAT3; the disease is diffuse large B-cell lymphoma.